We are live on ! Find out more
HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares

Delisted

HZNP was delisted on the 5th of October, 2023.

95 hedge funds and large institutions have $347M invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2013 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,391% more call options, than puts

Call options by funds: $11M | Put options by funds: $735K

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

192% more capital invested

Capital invested by funds: $119M → $347M (+$228M)

78% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 18

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

42% more funds holding

Funds holding: 6795 (+28)

Holders
95
Holders Change
+28
Holders Change %
+41.79%
% of All Funds
2.76%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
38
Increased
32
Reduced
18
Closed
9
Calls
$11M
Puts
$735K
Net Calls
+$10.2M
Net Calls Change
+$6.21M
Name Holding Trade Value Shares
Change
Change in
Stake
VKH
101
Virtu KCG Holdings
New York
-$74K -21,947 Closed
JP Morgan Chase
102
JP Morgan Chase
New York
-$64K -19,025 Closed
TH
103
Timber Hill
Connecticut
-$42K -12,667 Closed
SSG
104
Summit Securities Group
New York
-$8K -2,400 Closed

HZNP Hedge Fund Activity: Q4 2013 in Review

95 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q4 2013, worth a combined $347M — up 192% from $119M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new HZNP positions and 9 closed out — a net gain of 29 holders — while 32 added to existing stakes and 18 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $25M. The largest seller was Fidelity Investments, cutting an estimated $12M.

  • 95 institutional investors held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q4 2013, up from 67 in Q3 2013.
  • Funds reported $347M of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q4 2013, up 192% quarter-over-quarter.
  • 38 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q4 2013 and 9 closed out, a net change of +29 holders.
  • The largest Horizon Therapeutics Public Limited Company Ordinary Shares buyer in Q4 2013 was Deerfield Management, an estimated $25M added.
  • The largest Horizon Therapeutics Public Limited Company Ordinary Shares seller in Q4 2013 was Fidelity Investments, an estimated $12M sold.

Based on aggregated 13F filings for Q4 2013.